[Drug-induced nephropathy]

Area of Science:

• Nephrology
• Pharmacology
• Internal Medicine

Background:

• Drug-induced nephropathy is a significant cause of acute kidney injury and chronic renal insufficiency.
• Early clinical signs of drug-induced nephropathy are often absent, leading to delayed diagnosis and treatment.
• Patient comorbidities like diabetes mellitus, congestive heart failure, and older age increase susceptibility to kidney injury from medications.

Purpose of the Study:

• To review the primary clinical manifestations of drug-induced nephropathy.
• To highlight the importance of identifying modifiable patient risk factors for drug-induced kidney injury.
• To discuss common mechanisms underlying drug-induced renal damage.

Main Methods:

• Literature review of drug-induced nephropathy.
• Analysis of clinical presentations and risk factors.
• Examination of common nephrotoxic mechanisms.

Main Results:

• Drug-induced nephropathy can present insidiously, often detected only upon significant decline in renal function.
• Several drug classes possess nephrotoxic potential, necessitating awareness among healthcare providers.
• Patient-specific factors substantially impact the likelihood and severity of drug-induced renal injury.

Conclusions:

• Understanding the clinical spectrum of drug-induced nephropathy is vital for timely intervention.
• Individualized risk assessment is paramount to safely prescribing medications with known nephrotoxic potential.
• Prompt recognition and management can reverse early-stage drug-induced kidney damage.